The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
400 jobs Number of planned job creations
Announcement Date
21 June 2020
Employment effect (start)
Foreseen end date
Description
Kite, a subsidiary of American pharma company Gilead, has opened a 19,000 square meter factory in Hoofddorp. The new factory will produce a medicine to fight lymph node cancer and will significantly reduce the delivery time of this medicine for European cancer patients, who previously had to depend on shipment of the medicine from Los Angeles. The new factory will employ 400 persons upon opening, while expansion to 530 employees is expected in the near future. Kite is an American pharma company and was taken over by Gilead in 2017.
Eurofound (2020), Kite, Business expansion in Netherlands, factsheet number 101123, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101123.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
